Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
NewsWire
|
EPL Oil & Gas, Inc., an oil and natural gas exploration and production company, has reported a net income of $29.04 million, or $0.73 per diluted share, for the first quarter ended March 31, 2013, compared to $1.50 million, or $0.04 per diluted share, for the first quarter ended March 31, 2012.
Published By MarketLine
|
16 May 2013 |
|
NewsWire
|
Andhra Bank, has reported a net profit of INR3.44 billion, or INR6.16 per share, for the fourth quarter ended March 31, 2013, compared to INR3.4 billion, or INR6.07 per share, for the same quarter ended March 31, 2012.
Published By MarketLine
|
16 May 2013 |
|
NewsWire
|
M/A-COM Technology Solutions Holdings, Inc. has reported that net income attributable to common stockholders for the second quarter ended March 29, 2013 was $8.09 million, or $0.17 per diluted share, compared to a net loss attributable to common stockholders of $54.76 million, or $8.02 loss per diluted share, for the same quarter ended March 30, 2012. The company expects revenue to be in the range of $78 million to $82 million for the third quarter of fiscal 2013.
Published By MarketLine
|
16 May 2013 |
|
NewsWire
|
Madalena Ventures Inc., an upstream oil and gas company, has reported a net loss of C$5.07 million, or C$0.02 loss per share, for the fourth quarter ended December 31, 2012, compared to a net loss of C$1.58 million, or C$0.01 loss per share, for the fourth quarter ended December 31, 2011.
Published By MarketLine
|
16 May 2013 |
|
NewsWire
|
Zogenix, Inc., a pharmaceutical company developing products for the treatment of central nervous system disorders and pain, has announced positive results from its extended Phase I clinical trial of Relday, an investigational candidate of a proprietary, once-monthly subcutaneous formulation of risperidone for the treatment of schizophrenia.
Published By MarketLine
|
16 May 2013 |
|
NewsWire
|
West Pharmaceutical Services, Inc., a provider of systems for packaging and delivery of injectable drugs, has reported that net income for the first quarter ended March 31, 2013 was $31.7 million, or $0.90 per diluted share, compared to $29.2 million, or $0.81 per diluted share, for the same quarter ended March 31, 2012. The company expects diluted EPS to be in the range of $3.08 to $3.23 for 2013.
Published By MarketLine
|
16 May 2013 |
|
NewsWire
|
Sedasys, a division of Ethicon Endo-Surgery, Inc., has received premarket approval, or PMA, from FDA for the SEDASYS System, a computer-assisted personalized sedation, or CAPS, system.
Published By MarketLine
|
16 May 2013 |
|
NewsWire
|
SoftBank Corp., a provider of telecommunications and internet services, has reported that net income for fiscal 2013 was JPY289.4 billion, compared to JPY313.7 billion for fiscal 2012.
Published By MarketLine
|
16 May 2013 |
|
NewsWire
|
Primus Telecommunications Canada Inc. has announced a multi-year renewal of a partnership program as exclusive national provider of residential telecommunications services to Costco members.
Published By MarketLine
|
16 May 2013 |
|
NewsWire
|
Sigma-Tau Pharmaceuticals, Inc., a subsidiary of the Sigma-Tau Group, has launched CYSTARAN 0.44%, an FDA-approved therapy for the treatment of corneal cystine crystal accumulation in patients with cystinosis.
Published By MarketLine
|
16 May 2013 |
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.